Vasopressin marker copeptin and the development of renal and metabolic disorders in patients with type 2 diabetes

Abstract. The aim of the study was to evaluate the possibility of using copeptin as a marker of renal and metabolic dysfunction in patients with type 2 diabetes. Methods: In this cross-sectional, observational study included 78 patients with type 2 diabetes mellitus complicated by diabetic nephr...

Full description

Bibliographic Details
Main Authors: A. Nesen, K. Savicheva, P. Semenovykh, V. Galchiskaya
Format: Article
Language:English
Published: State Institution «Institute of Nephrology NAMS of Ukraine" 2022-06-01
Series:Український Журнал Нефрології та Діалізу
Subjects:
Online Access:https://ukrjnd.com.ua/index.php/journal/article/view/646